CN |CAS  
 
  Home | Links | Site map
 
Home About Us News Organization Research Faculty Publication Education&Training Contact
  Research
Location: Home > Research
 
 
Research
Target
Discovery
Development
Translation
 
SIMM discovers novel tubulin polymerization inhibitors
Update time: 2011-09-06
Close
Text Size: A A A
Print
                               
 

Top:Structures of representative compounds.Bottom: Antitubulin and antiproliferative activities of representative compounds.(Image by SIMM)

Anti-tubulin agents are widely used in clinic for the therapy of solid tumors. However, the toxicity and intrinsic or acquired resistances limit their clinical efficacy. Therefore, the search for novel anti-tubulin agents with higher efficacy and lower toxicity is of significant importance.

Through the tight collaboration between LOU Liguang’s group and HU Youhong’s group at Shanghai Institute of Materia Medica, CAS,a novel series of 2,4,5-substituted pyrimidine derivatives have been designed, synthesized and evaluated for their biological activity. These pyrimidine derivatives inhibit purified tubulin polymerization through binding to tubulin at the colchicine-binding site, induce G2/M cell-cycle arrest and inhibit human tumor cell proliferation. Some indole-pyrimidine compounds may have great potential for further development as anticancer therapeutics.

This work was supported by National Science & Technology Major Project“Key New Drug Creation and Manufacturing Program”and the National Natural Science Foundation of China. This work has been published in the Journal of Medicinal Chemistry (2011, 54:2127-2142)

Full text: http://pubs.acs.org/doi/abs/10.1021/jm101388d

 
weimoban
About Us News Research Faculty Education&Trainning Organization Contact
Brief Introduction
History
Address from the Director
Directors
Administration
Research
Events
Int'l cooperation
Target
Discovery
Development
Translation
Academician
PI
Graduate Students
Post Graduate Students